Seoul: South Korean pharmaceutical company Celtrian Inc. has announced that its experimental antibody is not only effective but also safe in the treatment of the novel coronavirus epidemic ‘Covid 19’.
According to the Reuters news agency, in a large-scale global medical trial (Phase 3 clinical trials), this experimental antibody recovered people infected with corona about five days ago.
Medical trials of the antibody began in January this year in 13 countries, including South Korea, the United States, Spain and Romania. 1,315 volunteers took part in the trials.
During this treatment, more than 70% of the patients with severe symptoms of Covid 19 also recovered completely.
It should be noted that South Korea had given conditional permission for the treatment of coronavirus through antibodies in February this year.
Celltrion says she will seek “full approval” for her proposed treatment based on the latest findings